PHASE I DOSE ESCALATING STUDY OF RHIL 12 WITH ADVANCED MALIGNANCIES
PHASE I DOSE ESCALATING STUDY OF RHIL 12 WITH ADVANCED MALIGNANCIES
批准号:
3743204
负责人:
MICHAEL S GORDON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We will be conducting a phase I trial with the new biological response
modifier rhIL-12. rhIL-12 has been shown to possess a wide variety of
immunologic effects which include the enhancement of anti-tumor activity
of various effector cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Age and Temporal Processing of Audiovisual Speech
-
批准号:6989721
-
项目类别:
-
资助金额:$3.28万
-
财政年份:2003
-
负责人:MICHAEL S GORDON
-
依托单位:
Age and Temporal Processing of Audiovisual Speech
-
批准号:6694557
-
项目类别:
-
资助金额:$3.42万
-
财政年份:2003
-
负责人:MICHAEL S GORDON
-
依托单位:
Age and Temporal Processing of Audiovisual Speech
-
批准号:6804858
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2003
-
负责人:MICHAEL S GORDON
-
依托单位:
Age and Temporal Processing of Audiovisual Speech
-
批准号:6992186
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2003
-
负责人:MICHAEL S GORDON
-
依托单位:
PHASE IB TRIAL OF RHIL-6 IN METASTATIC BREAST CANCER
-
批准号:3743203
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL S GORDON
-
依托单位:
PHASE I, OPEN LABEL, ESCALATING DOSETRIAL OF SDZ 969 IN MYELODYSPLASTIC PATIENTS
-
批准号:3743126
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL S GORDON
-
依托单位:
R-METHUSCF AND FILGRASTAM IN HIGH-GRADE NON-HODGKIN'S LYMPHOMA
-
批准号:3743157
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL S GORDON
-
依托单位:
RECOMBINANT HUMAN INTERLEUKIN-2 IN PATIENTS WITH INVASIVE THYMOMA
-
批准号:3743129
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL S GORDON
-
依托单位:
SDZ ILS 969 WITH MAID CHEMOTHERAPY IN PATIENTS WITH NO PRIOR THERAPY FOR SARCOMA
-
批准号:3743130
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL S GORDON
-
依托单位:
PHASE I DOSE ESCALATING STUDY OF RECOMBINANT HUMAN INTERLEUKIN 12
-
批准号:3743224
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MICHAEL S GORDON
-
依托单位:
海外基金